New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1.8 mg/ml;   - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 0.182 mg/ml;   - solution for injection - 1:10000 - active: adrenaline acid tartrate 0.182 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 1mg;   - solution for injection - 1mg/10ml - active: adrenaline 1mg   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite tartaric acid water for injection - adrenaline 1:10,000. an adjunct in the management of cardiac arrest.

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma egypt - injection - 1 mg/ml

Malta - English - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg - antineoplastic agents

United Kingdom - English - myHealthbox

cipla (eu) limited - cisplatin. - concentrate for solution for infusion - 1mg/ml - other antineoplastic agents, pla - for the treatment of: • advanced or metastatic testicular cancer • advanced or metastatic ovarian cancer • advanced or metastatic bladder carcinoma • advanced or metastatic squamous cell carcinoma of the head and neck • advanced or metastatic non-small cell lung carcinoma • advanced or metastatic small cell lung carcinoma

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - xylometazoline hydrochloride - nasal spray solution - 1 mg/ml - sympathomimetics, plain

Canada - English - Health Canada

wyeth-ayerst canada inc. - propranolol hydrochloride - liquid - 1mg - propranolol hydrochloride 1mg - beta-adrenergic blocking agents

Malta - English - Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/5ml - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - adrenaline (epinephrine), quantity: 0.5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.